{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T15:40:15Z","timestamp":1719243615768},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,6,3]],"date-time":"2017-06-03T00:00:00Z","timestamp":1496448000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s00125-017-4319-y","type":"journal-article","created":{"date-parts":[[2017,6,3]],"date-time":"2017-06-03T05:48:29Z","timestamp":1496468909000},"page":"1382-1384","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Metabolically inactive insulin: friend or foe in the prevention of autoimmune diabetes?"],"prefix":"10.1007","volume":"60","author":[{"given":"Mikael","family":"Knip","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,6,3]]},"reference":[{"key":"4319_CR1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/17402520500078204","volume":"12","author":"JM Jasinski","year":"2005","unstructured":"Jasinski JM, Eisenbarth GS (2005) Insulin as a primary autoantigen for type 1A diabetes. Clin Dev Imunol 12:181\u2013186","journal-title":"Clin Dev Imunol"},{"key":"4319_CR2","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nature03523","volume":"435","author":"M Nakayama","year":"2005","unstructured":"Nakayama M, Abiru N, Moriyama H et al (2005) Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature 435:220\u2013223","journal-title":"Nature"},{"key":"4319_CR3","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.clim.2013.02.002","volume":"149","author":"KT Coppieters","year":"2013","unstructured":"Coppieters KT, Harrison LC, von Herrath MG (2013) Trials in type 1 diabetes: antigen-specific therapies. Clin Imunol 149:345\u2013355","journal-title":"Clin Imunol"},{"key":"4319_CR4","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.2337\/diacare.28.7.1630","volume":"28","author":"JS Skyler","year":"2005","unstructured":"Skyler JS, Krischer JP, Wolsdorf J et al (2005) Effects of oral insulin in relatives of patients with type 1 diabetes: the diabetes prevention trial\u2014type 1. Diabetes Care 28:1068\u20131076","journal-title":"Diabetes Care"},{"key":"4319_CR5","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1007\/s00125-004-1517-1","volume":"47","author":"BO Roep","year":"2004","unstructured":"Roep BO, Atkinson M (2004) Animal models have little to teach us about type 1 diabetes: 1. In support of this proposal. Diabetologia 47:1650\u20131656","journal-title":"Diabetologia"},{"key":"4319_CR6","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.2337\/db13-0300","volume":"62","author":"J Ilonen","year":"2013","unstructured":"Ilonen J, Hammais A, Laine A-P et al (2013) Patterns of \u03b2-cell autoantibody appearance and genetic associations during the first years of life. Diabetes 62:3636\u20133640","journal-title":"Diabetes"},{"key":"4319_CR7","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1007\/s00125-015-3514-y","volume":"58","author":"JP Krischer","year":"2015","unstructured":"Krischer JP, Lynch KF, Schatz DA et al (2015) The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study. Diabetologia 58:980\u2013987","journal-title":"Diabetologia"},{"key":"4319_CR8","doi-asserted-by":"crossref","first-page":"8384","DOI":"10.1073\/pnas.0932778100","volume":"100","author":"SM Lieberman","year":"2003","unstructured":"Lieberman SM, Evans AM, Han B et al (2003) Identification of the beta cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes. Proc Natl Acad Sci 100:8384\u20138388","journal-title":"Proc Natl Acad Sci"},{"key":"4319_CR9","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1172\/JCI117707","volume":"95","author":"A Muir","year":"1995","unstructured":"Muir A, Peck A, Clare-Salzler M et al (1995) Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription. J Clin Invest 95:628\u2013634","journal-title":"J Clin Invest"},{"key":"4319_CR10","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1172\/JCI119654","volume":"100","author":"DG Karounos","year":"1997","unstructured":"Karounos DG, Bryson JS, Cohen DA (1997) Metabolically inactive insulin analog prevents type I diabetes in prediabetic NOD mice. J Clin Invest 100:1344\u20131348","journal-title":"J Clin Invest"},{"key":"4319_CR11","doi-asserted-by":"publisher","unstructured":"Gr\u00f6nholm J, Pagni PP, Pham MN et al (2017) Metabolically inactive insulin analogue does not prevent autoimmune diabetes in non-obese diabetic mice. Diabetologia. doi: 10.1007\/s00125-017-4276-5","DOI":"10.1007\/s00125-017-4276-5"},{"key":"4319_CR12","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1084\/jem.20110574","volume":"208","author":"C Daniel","year":"2011","unstructured":"Daniel C, Weigmann B, Bronson R, von Boehmer H (2011) Prevention of type 1 diabetes in mice by tolerogenic vaccination with a strong agonist insulin mimetope. J Exp med 208:1501\u20131510","journal-title":"J Exp med"},{"key":"4319_CR13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1084\/jem.20022125","volume":"198","author":"MJ Ansari","year":"2003","unstructured":"Ansari MJ, Salama AD, Chitnis T et al (2003) The programmed death-1 (PD1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J Exp Med 198:63\u201369","journal-title":"J Exp Med"},{"key":"4319_CR14","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.4049\/jimmunol.163.4.1833","volume":"163","author":"D Homann","year":"1999","unstructured":"Homann D, Dyrberg T, Petersen J, Oldstone MB, von Herrath MG (1999) Insulin in oral immune \u201ctolerance\u201d: a one-amino acid change in the B chain makes the difference. J Immunol 163:1833\u20131838","journal-title":"J Immunol"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-017-4319-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-017-4319-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-017-4319-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T15:08:50Z","timestamp":1719241730000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-017-4319-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,3]]},"references-count":14,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["4319"],"URL":"https:\/\/doi.org\/10.1007\/s00125-017-4319-y","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,3]]}}}